Not available
Quote | Cidara Therapeutics Inc. (NASDAQ:CDTX)
Last: | $0.7222 |
---|---|
Change Percent: | 0.96% |
Open: | $0.723 |
Close: | $0.7222 |
High: | $0.8 |
Low: | $0.7101 |
Volume: | 421,346 |
Last Trade Date Time: | 04/17/2024 03:00:00 am |
News | Cidara Therapeutics Inc. (NASDAQ:CDTX)
- Multispecific CD73/PD-1 DFC demonstrates improved tumor reduction compared to PD-1 monotherapy in nonclinical study - CCR5-targeting DFC demonstrates potent efficacy in colorectal cancer mouse model - Late-breaking CBO421 data demonstrates improved efficacy compared to oleclumab...
2024-04-03 08:53:52 ET More on premarket gainers & stock Aldeyra: Derisked Biotech Eyeing Path To Approval And Finalizing Deal With AbbVie Why Aldeyra Therapeutics Is A Strong Buy: AbbVie Agreement And Reproxalap's Prospects SELLAS Life Sciences GAAP EPS of -$1.3...
Message Board Posts | Cidara Therapeutics Inc. (NASDAQ:CDTX)
Subject | By | Source | When |
---|---|---|---|
$CDTX Should be up bigly tomorrow. Pres and | MiamiGent | investorshub | 03/28/2023 12:32:15 AM |
$CDTX Just added @ .95 | MiamiGent | investorshub | 03/27/2023 4:27:23 PM |
Interesting announcement by 5AM Ventures..... they | now invest | investorshub | 03/23/2023 2:52:53 PM |
Hello Ed. Also check out $ADRX. That one | enthalpy | investorshub | 03/23/2023 12:47:37 PM |
still losing money but is is narrowing | ed3/6me | investorshub | 03/23/2023 12:00:27 PM |
News, Short Squeeze, Breakout and More Instantly...
Cidara Therapeutics Inc. Company Name:
CDTX Stock Symbol:
NASDAQ Market:
Cidara Therapeutics Inc. Website:
- Multispecific CD73/PD-1 DFC demonstrates improved tumor reduction compared to PD-1 monotherapy in nonclinical study - CCR5-targeting DFC demonst...
- Multispecific CD73/PD-1 DFC demonstrates improved tumor reduction compared to PD-1 monotherapy in nonclinical study - CCR5-targeting DFC demonstrates potent efficacy in colorectal cancer mouse model - Late-breaking CBO421 data demonstrates improved efficacy compared to oleclumab...
Swire Pacific Ltd. ADR (Class A) (SWRAY) is expected to report for Q4 2023 Troika Media Group Inc. (TRKAQ) is expected to report for quarter end 2023-12-31 American Environmental Partners Inc. (AEPT) is expected to report for quarter end 2023-12-31 Veolia Environnement S.A. ADR (VEOEY...